[HT942526JWMRPMMRDA] DoW Joint Warfighter Medical, Military Medical Research and Development Award

Description

Titolo: DoW Joint Warfighter Medical, Military Medical Research and Development Award Numero dell'opportunità: HT942526JWMRPMMRDA Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: Defense Health Agency Contracting Activity - DHACA — Department of Defense Tipo di finanziamento: Cooperative Agreement; Grant; Other; Procurement Contract Categoria: Science and Technology and other Research and Development Programma (ALN): 12.420 Military Medical Research and Development Pubblicato il: 2026-06-17 Scadenza per le domande: 2026-11-16 Finanziamento totale stimato: 8,800,000 USD Numero di finanziamenti attesi: 4 Cofinanziamento richiesto: no Chi può fare domanda: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Descrizione: Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas. Distinctive Features: To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding. An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials. Contatto: [email protected]

Sectors

Source

Source: grants.gov